Clinical studies recruiting near Southport

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Phase 3 · Gold Coast University Hospital-Cancer and Blood Disorders Cl · Merck Sharp & Dohme LLC · NCT06351631 Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Phase 4 · Glaukos Corporation · NCT06848946 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Kallyope Inc. · NCT07674654 Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Phase N/A · Glaukos Corporation · NCT07400926 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · Gold Coast University Hospital · University of Melbourne · NCT04434807 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · PrECOG, LLC. · NCT06538038 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Gold Coast University Hospital · Eli Lilly and Company · NCT07369011 ROADMAP Clinical Trial
Phase 4 · Gold Coast University Hospital · University of Newcastle, Australia · NCT06771050 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213 Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Q · PYC Therapeutics · NCT06714006 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Gold Coast University Hospital · Biogen · NCT06962800 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Griffith Health · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · North West Regional Spinal Injuries Centre · St George's, University of London · NCT04936620 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Tasman Oncology Research ( Site 2104) · Merck Sharp & Dohme LLC · NCT06623422 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 Pan Tumor Rollover Study
Phase 2 · Tasman Oncology Research Ltd · Bristol-Myers Squibb · NCT03899155 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Tasman Oncology Research Ltd · BioNTech SE · NCT07070232 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Gold Coast University Hospital · Eli Lilly and Company · NCT07223593 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Gold Coast Hospital and Health Service- Gold Coast Universit · Monash University · NCT05072314 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Gold Coast University Hospital · Eli Lilly and Company · NCT06119581 Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Phase 1 · Tasman Oncology Research Ltd · BioNTech SE · NCT06750185 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · Icon Cancer Centre Southport · X4 Pharmaceuticals · NCT06056297 The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · Gold Coast Hospital and Health Service · The George Institute · NCT06058585

Look up another city

Look up another condition